laboratory diagnosis of infections in immunocompromised ... · syndromic approach- fevers fuo...
TRANSCRIPT
Laboratory Diagnosis of Infections in Immunocompromised patients: A syndromic
approach
DrAr%KapilProfessor,DepartmentofMicrobiology
AIIMS,NewDelhi
Challenges in Specific Diagnosis
• Typical presentation with localization is not present • Multiple simultaneous infections can occur • Non infectious etiology presenting like infections • Wide differential diagnosis • Causes range from all community acquired to opportunistic
• Low threshold of diagnostic suspicion is needed • Laboratory strategies broad based – prioritize based on common agent in
the clinical setting
2DelhiChapterIAMMaaapril2016
Clinical Information
Underlying factors • Type of immunocompromised state • Associated risk factors • Duration of immunocompromised state Localization • Respiratory involvement • Neurological symptoms • Skins and soft tissue infection • diarrhoea
3DelhiChapterIAMMaaapril2016
Focusofinfec+on %ofPa+entPulmonary 39.02Gastrointes+nal 18.29Infec+onsofunknownorigin 30.49Bone 1.22Centralnervoussystem 2.44Intravenoussite 1.22Skin 1.22Urinarytractinfec+ons 1.22
Respiratoryandgastrointes+nal 3.66Skin 1.22
Focus of infection documented in Febrile Neutropenia patients
4DelhiChapterIAMMaaapril2016 AIIMSstudy2015
5
Syndromic approach
DelhiChapterIAMMaaapril2016 6
Syndromic approach- FEVERS
FUO commonly Febrile neutropenia • GNB,GPC and fungal infections
Sepsis • Central line associated blood stream infections • Mucositis and secondary bacteremias
7DelhiChapterIAMMaaapril2016
8
9
Approach to lab diagnosis -specimen
Blood for culture • Volume of blood remains the most important variable • Media to cover Bacterial and fungal • Collection under all ascetic techniques • Central line and peripheral collections
• Automated methods help in early detection • Time to culture positivity for CLABSI or CRBSI • Antimicrobial susceptibility testing
10DelhiChapterIAMMaaapril2016
Pulmonary syndromes
Fever and new pulmonary infiltrates
• Conventional respiratory pathogens • nosocomial respiratory pathogens • “Atypical” organisms- Mycobacteria, fungi, viruses, parasites
• Radiological investigations are most important
11DelhiChapterIAMMaaapril2016
Approach to lab diagnosis -specimen
Respiratory – BAL most appropriate • Induced sputum or expectorated sputum next best choice
• Direct microscopy , KOH, gram stain, calcofluor white, ZN staining, IFA
• Culture for fungi and Mycobacteria • Quantitative cultures for bacteria • PCR based tests for viruses – CMV
12DelhiChapterIAMMaaapril2016
DelhiChapterIAMMaaapril2016 13
KOH Preparation
Septatehyphae
Broadaseptatehyphae
Calcofluor stain
Broadnonseptatehyphae
Buddingyeastcells
Pseudohyphae
P.jeroveciiwithcalcofluorwhite
Fromaptwithdyspaneawheezinghemoptysis,nausea,vomi%ngDiarrhoea,gramnega%vesepsisEDGandBAL–Strongyloidesstercoralis
Considerscreeiningwithserologicaltestsforstrongyloidesin“atrisk“fromendemicarea
16DelhiChapterIAMMaaapril2016
Stronglyloidosis
DelhiChapterIAMMaaapril2016 17
Characteris+csofthemainserologicaltestsforstrongyloidiasis
Requena-MéndezA,ChiodiniP,BisoffiZ,BuonfrateD,GotuzzoE,etal.(2013)TheLaboratoryDiagnosisandFollowUpofStrongyloidiasis:ASystema%cReview.PLoSNeglTropDis7(1):e2002.doi:10.1371/journal.pntd.0002002hdp://journals.plos.org/plosntds/ar%cle?id=info:doi/10.1371/journal.pntd.0002002
Gastrointestinal syndromes
Stomatitis • Candida, HSV and chemotherapy induced
Diarrhoea • Conventional infections ( dd GVHD) • CDI colitis
Liver function derangements • CMV and toxoplasmosis
18DelhiChapterIAMMaaapril2016
Approach to lab diagnosis -specimen
Stool specimen • Parasitic ova and cysts – esp coccidian parasites and microsporidia • Cryptosporidium, Giardia • Strongyloides
• Bacterial cultures – Salmonella , Shigella , campylobacter
• CDI toxin assay
19DelhiChapterIAMMaaapril2016
Parasi%ccystsinstool20
DelhiChapterIAMMaaapril2016
Skin and soft tissue infections
• Infections in devitalized tissues • Undrained fluid collections • Cutaneous manifestations of fungal infections
Biopsy or tissue • Histopathology and microscopy • Culture – Bacterial, Mycobacterial, fungal
21DelhiChapterIAMMaaapril2016
Prolongedgranulocytopenia-Fusarium
22DelhiChapterIAMMaaapril2016
Acute Neurological syndromes
Meningoencephalitis • conventional bacterial pathogens • Tuberculosis, HSV • Fungi – cryptococcus and candida Space occupying lesion type • Toxoplasma, aspergillus and nocardia CSF • Direct microscopy for bacteria and fungi • Bacterial, fungal or viral culture • Antigen detection - cryptococcal or bacterial or viral
23DelhiChapterIAMMaaapril2016
Urinary tract Infections
• Community acquired infections • Catheter associated Urine • Bacterial culture • CMV inclusions - Microscopy • Cryptococcal or legionella antigen • Lipoarabinomannan assay for TB
24DelhiChapterIAMMaaapril2016
DelhiChapterIAMMaaapril2016
Biomarkers
• Procalcitonin – Bacterial spesis • Galactomannan – Invasive aspergillosis • β D Glucan – Invasive fungal infections • Lipoarabinomannan - tuberculsosis
26DelhiChapterIAMMaaapril2016
Variables OR (at 95%CI) Sensit ivity%
Specif ic ity% PPV% NPV%
PCT ≥ 0.25 1.15 (0.33 - 4.03) 73.3 29.4 18.6 83.3
CRP ≥ 110 0.52 (0.10 - 2.61) 13.3 77.2 13.3 77.2
Procalcitonin (PCT) in febrile neutropenic episodes of children undergoing treatment for childhood cancers
AIIMSstudyunderpublica%on27DelhiChapterIAMMaaapril2016
28DelhiChapterIAMMaaapril2016
29DelhiChapterIAMMaaapril2016
30DelhiChapterIAMMaaapril2016
Diagnosis of Tuberculosis
TST • >5mm in HIV or immunocompromised host
Interferon–Gamma Release Assays (IGRAs) • QuantiFERON®-TB Gold-in-Tube test (QFT-GIT)- amount of IFN-γ released • T-SPOT® TB test - number of cells that release IFN-γ
Unaffected by BCG and most environmental mycobacteria.
Limited data exist on use in immunocompromised persons and those who need serial testing.
• All in addition to X ray, smear and culture and clinical findings
DelhiChapterIAMMaaapril2016 31
32DelhiChapterIAMMaaapril2016
33DelhiChapterIAMMaaapril2016
CMV Diagnosis
Summary of tests used for CMV diagnosis
34DelhiChapterIAMMaaapril2016
DelhiChapterIAMMaaapril2016 35
Tests before Transplant - recipient
All patients • CMV , HSV, VZV, EBV, HIV, HBV*, HCV (quantitative assays) • VDRL , urine culture, • Mantoux, chest X ray • Toxoplasma * HBSAg, Anti HBS, Anti HBc ( core ag)
Pt in endemic areas/ exposure history • Strongyloides, Leishmania, Coccidian parasites • Histoplasma, Cryptococcus
36DelhiChapterIAMMaaapril2016
Screening of donors
• Any acute infection • HIV • Rabies • Hepatitis viruses
37DelhiChapterIAMMaaapril2016
Thank you.
All India Institute of Medical Sciences, New Delhi, India!